-
Something wrong with this record ?
Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast
D Grochova, J Vankova, J Damborsky, B Ravcukova, J Smarda, B Vojtesek, J Smardova
Language English Country Great Britain
Grant support
NR8068
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
ProQuest Central
from 2000-01-01 to 1 year ago
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 1997-01-09 to 2015-11-26
Health & Medicine (ProQuest)
from 2000-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2000-01-01 to 1 year ago
- MeSH
- Transcriptional Activation genetics drug effects genetics MeSH
- Amifostine pharmacology MeSH
- Financing, Organized MeSH
- Protein Conformation drug effects MeSH
- Humans MeSH
- Tumor Suppressor Protein p53 biosynthesis genetics chemistry MeSH
- Radiation-Protective Agents pharmacology MeSH
- Saccharomyces cerevisiae Proteins genetics drug effects MeSH
- Amino Acid Substitution genetics MeSH
- Temperature MeSH
- Check Tag
- Humans MeSH
The p53 gene is often mutated during cancer development. Frequency and functional consequences of these mutations vary in different tumor types. We analysed conformation and temperature dependency of 23 partially inactivating temperature-dependent (td) p53 mutants derived from various human tumors in yeast. We found considerable differences in transactivation capabilities and discriminative character of various p53 mutants. No correlations in transactivation rates and conformations of the td p53 proteins were detected. Amifostine-induced p53 reactivation occurred only in 13 of 23 td mutants, and this effect was temperature dependent and responsive element specific. The most of the p53 mutations (10/13) reactivated by amifostine were located in the part of the p53 gene coding for hydrophobic beta-sandwich structure of the DNA-binding domain.
- 000
- 00000naa 2200000 a 4500
- 001
- bmc10026412
- 003
- CZ-PrNML
- 005
- 20130814101910.0
- 008
- 101018s2008 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Nikulenkov Grochová, Diana. $7 mub20181016842
- 245 10
- $a Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast / $c D Grochova, J Vankova, J Damborsky, B Ravcukova, J Smarda, B Vojtesek, J Smardova
- 314 __
- $a Department of Pathology, University Hospital, Brno, Czech Republic.
- 520 9_
- $a The p53 gene is often mutated during cancer development. Frequency and functional consequences of these mutations vary in different tumor types. We analysed conformation and temperature dependency of 23 partially inactivating temperature-dependent (td) p53 mutants derived from various human tumors in yeast. We found considerable differences in transactivation capabilities and discriminative character of various p53 mutants. No correlations in transactivation rates and conformations of the td p53 proteins were detected. Amifostine-induced p53 reactivation occurred only in 13 of 23 td mutants, and this effect was temperature dependent and responsive element specific. The most of the p53 mutations (10/13) reactivated by amifostine were located in the part of the p53 gene coding for hydrophobic beta-sandwich structure of the DNA-binding domain.
- 650 _2
- $a amifostin $x farmakologie $7 D004999
- 650 _2
- $a substituce aminokyselin $x genetika $7 D019943
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a konformace proteinů $x účinky léků $7 D011487
- 650 _2
- $a radioprotektivní látky $x farmakologie $7 D011837
- 650 _2
- $a Saccharomyces cerevisiae - proteiny $x genetika $x účinky léků $7 D029701
- 650 _2
- $a teplota $7 D013696
- 650 _2
- $a aktivace transkripce $x genetika $x účinky léků $7 D015533
- 650 _2
- $a aktivace transkripce $x genetika $7 D015533
- 650 _2
- $a nádorový supresorový protein p53 $x biosyntéza $x genetika $x chemie $7 D016159
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Vaňková, J. $7 _AN038365
- 700 1_
- $a Damborský, Jiří, $d 1969- $7 mzk2006348900
- 700 1_
- $a Ravčuková, Barbora $7 xx0105242
- 700 1_
- $a Šmarda, Jan, $d 1961- $7 mzk2006343362
- 700 1_
- $a Vojtěšek, Bořivoj, $d 1960- $7 xx0001694
- 700 1_
- $a Šmardová, Jana, $d 1961- $7 mzk2005304278
- 773 0_
- $w MED00003600 $t Oncogene $g Roč. 27, č. 9 (2008), s. 1243-1252 $x 0950-9232
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110112144541 $b ABA008
- 991 __
- $a 20130814102419 $b ABA008
- 999 __
- $a ok $b bmc $g 801517 $s 666267
- BAS __
- $a 3
- BMC __
- $a 2008 $b 27 $c 9 $d 1243-1252 $m Oncogene $n Oncogene $x MED00003600
- GRA __
- $a NR8068 $p MZ0
- LZP __
- $a 2010-B/mk